Company research / LFWD

Lifeward Ltd. (LFWD)

CIK 0001607962 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Lifeward Ltd. reported revenue of $22.03M. Revenue fell 14.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $21.82M.

Key ratios (year ended 2025-12-31)

38.2%
Gross margin
-89.3%
Operating margin
-90.4%
Net margin
-236.8%
Return on year-end equity
-14.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-7, first reflected in a filing dated 2024-05-15; 1-for-12, first reflected in a filing dated 2026-03-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$21.82M$22.03M$25.66M$13.85M$5.51M$5.97M$4.39M$4.87M$6.54M$7.75M$5.87M
Cost of Revenue$13.98M$13.61M$17.45M$9.40M$3.61M$3.06M$2.20M$2.15M$3.72M$4.65M$5.13M
Gross Profit$7.85M$8.43M$8.22M$4.45M$1.91M$2.90M$2.19M$2.73M$2.83M$3.10M$736.0K
R&D Expense$9.16M$3.25M$4.62M$4.15M$4.03M$2.94M$3.46M$5.35M$7.35M$6.04M$9.03M
Operating Income-$22.75M-$19.67M-$29.35M-$23.61M-$19.10M-$12.65M-$12.00M-$14.05M-$19.21M-$21.99M-$30.44M
Depreciation & Amortizationn/an/an/an/an/an/an/an/an/a$642.0K$696.0K
EBITDAn/an/an/an/an/an/an/an/an/a-$21.35M-$29.75M
Net Income-$30.83M-$19.91M-$28.94M-$22.13M-$19.57M-$12.74M-$12.98M-$15.55M-$21.68M-$24.72M-$32.50M
EPS (Diluted)n/a-$17.16-$39.96-$31.13-$2.20-$0.27-$0.82n/an/an/an/a
Total Assets$35.00M$22.90M$30.49M$63.19M$74.24M$94.75M$28.07M$24.37M$14.96M$22.86M$31.76M
Total Liabilities$22.78M$14.49M$11.64M$16.68M$6.07M$5.37M$6.29M$13.59M$13.02M$19.16M$23.50M
Shareholders' Equity$12.22M$8.41M$18.85M$46.51M$68.17M$89.38M$21.77M$10.78M$1.95M$3.71M$8.26M
Cash & Equivalents$9.45M$2.17M$6.75M$28.08M$67.90M$88.34M$20.35M$16.25M$9.55M$14.57M$23.68M
Operating Cash Flow-$17.08M-$16.83M-$21.72M-$20.67M-$17.89M-$11.47M-$12.59M-$14.81M-$14.77M-$22.46M-$26.75M
Capital Expenditures$19.0K$16.0K$0$81.0K$25.0K$47.0K$73.0K$22.0K$13.0K$21.0K$452.0K
Free Cash Flow-$17.10M-$16.84M-$21.72M-$20.75M-$17.92M-$11.52M-$12.66M-$14.84M-$14.79M-$22.48M-$27.20M
Shares Outstanding2.83M1.52M734.0K8.59M60.09M62.48M25.33M7.32M2.81M30.00M16.34M
Weighted Average Diluted Sharesn/a1.16M724.3K710.9K8.91M47.94M15.76Mn/an/an/an/a
EPS (Basic)n/a-$17.16-$39.96-$31.13-$2.20-$0.27-$0.82n/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView